Characterization of protein arginine methyltransferases in porcine brain

被引:0
|
作者
Hung, Chien-Jen
Chen, Da-Huang
Shen, Yi-Ting
Li, Yi-Chen
Lin, Yi-Wei
Hsieh, Mingli
Li, Chuan [1 ]
机构
[1] Chung Shan Med Univ, Dept Biomed Sci, Taichung, Taiwan
[2] Chung Shan Med Univ, Inst Med, Taichung, Taiwan
[3] Tunghai Univ, Dept Biol, Taichung 40704, Taiwan
来源
关键词
arginine methylation; methylarginine containing proteins; PRMT;
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Protein arginine methylation is a posttranslational modification involved in various cellular functions including cell signaling, protein subcellular localization and transcriptional regulation. We analyze the protein arginine methyltransferases (PRMTs) that catalyze the formation of methylarginines in porcine brain. We fractionated the brain extracts and determined the PRMT activities as well as the distribution of different PRMT proteins in subcellular fractions of porcine brain. The majority of the type I methyltransferase activities that catalyze the formation of asymmetric dimethylarginines was in the cytosolic S3 fraction. High specific activity of the methyltransferase was detected in the S4 fraction (high-salt stripping of the ultracentrifugation precipitant P3 fraction), indicating that part of the PRMT was peripherafly associated with membrane and ribosomal fractions. The amount and distribution of PRMT1 are consistent with the catalytic activity. The elution patterns from gel filtration and anion exchange chromatography also indicate that the type I activity in S3 and S4 are mostly from PRMT1. Our results suggest that part of the type I arginine methyltransferases in brains, mainly PRMT1, are sequestered in an inactive form as they associated with membranes or large subceHular complexes. Our biochemical analyses confirmed the complex distribution of different PRMTs and implicate their regulation and catalytic activities in brain.
引用
收藏
页码:617 / 624
页数:8
相关论文
共 50 条
  • [1] Protein arginine methyltransferases and cancer
    Yang, Yanzhong
    Bedford, Mark T.
    NATURE REVIEWS CANCER, 2013, 13 (01) : 37 - 50
  • [2] Protein arginine methyltransferases and cancer
    Yanzhong Yang
    Mark T. Bedford
    Nature Reviews Cancer, 2013, 13 : 37 - 50
  • [3] PROTEIN ARGININE METHYLTRANSFERASES AND THEIR INFLUENCE ON EPIGENOME
    Janisiak, Joanna
    Kopytko, Patrycja
    Tarnowski, Maciej
    POSTEPY BIOLOGII KOMORKI, 2020, 47 (02) : 177 - 196
  • [4] Chemical probes for protein arginine methyltransferases
    Li, Alice Shi Ming
    Li, Fengling
    Eram, Mohammad S.
    Bolotokova, Albina
    dela Sena, Carlo C.
    Vedadi, Masoud
    METHODS, 2020, 175 : 30 - 43
  • [5] Protein arginine methyltransferases: guardians of the Arg?
    Fackelmayer, FO
    TRENDS IN BIOCHEMICAL SCIENCES, 2005, 30 (12) : 666 - 671
  • [6] Protein arginine methyltransferases in protozoan parasites
    Rodriguez, Mario Alberto
    PARASITOLOGY, 2022, 149 (04) : 427 - 435
  • [7] Protein arginine methyltransferases in cerebral ischemia
    do Couto e Silva, A.
    Possoit, H. E.
    Clemons, G. A.
    Citadin, C. T.
    Lin, H.
    JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2019, 39 : 455 - 455
  • [8] Increased protein arginine methylation in chronic hypoxia - Role of protein arginine methyltransferases
    Yildirim, Ali O.
    Bulau, Patrick
    Zakrzewicz, Dariusz
    Kitowska, Kamila E.
    Weissmann, Norbert
    Grimminger, Friedrich
    Morty, Rory E.
    Eickelberg, Oliver
    AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 2006, 35 (04) : 436 - 443
  • [9] Protein Arginine Methyltransferases in Cardiovascular and Neuronal Function
    Alexandre Couto e Silva
    Celeste Yin-Chieh Wu
    Cristiane T. Citadin
    Garrett A. Clemons
    HarLee E. Possoit
    Mychal S. Grames
    Chih-Feng Lien
    Alireza Minagar
    Reggie Hui-Chao Lee
    Adam Frankel
    Hung Wen Lin
    Molecular Neurobiology, 2020, 57 : 1716 - 1732
  • [10] Small Molecule Inhibitors of Protein Arginine Methyltransferases
    Hu, Hao
    Qian, Kun
    Ho, Meng-Chiao
    Zheng, Y. George
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2016, 25 (03) : 335 - 358